myeloproliferative neoplasm Clinical Research Trials

Please select a valid location from the dropdown

Found 175 clinical trials

Dual Vaccine Trial in Myeloproliferative Neoplasms

A phase I-II study in patients with mutated MPN by vaccinating with PD-L1 and Aginase1 peptides with Montanide ISA-51 as adjuvant, to monitor the immunological response to vaccination and

pd-l1 peptide

polycythemia vera

essential thrombocythemia

myeloproliferative disorder

thrombocytosis

0 views
23 Jan, 2021

A Study of TQ05105 Tablets in Subjects With Myeloproliferative Neoplasms

TQ05105 is a JAK2 inhibitors and can be used to treat JAK2 target-related diseases. The activation of the JAK/STAT pathway is related to abnormal proliferation, obstruction of apoptosis, and differentiation disorder of leukemia cells which is caused by genetic abnormalities and viral infection.

myelofibrosis

polycythemia

bone marrow procedure

leukemia

0 views
24 Jan, 2021
2 locations

Remotely Administered Diet Intervention to Impact Symptom Burden in Myeloproliferative Neoplasm

Myeloproliferative Neoplasm (MPN) is a chronic blood cancer without cure. The major clinical issues in MPN are 1) an increased risk of blood clots 2) symptoms thought to be driven by chronic

0 views
18 Feb, 2021
1 location

Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN Patients

patients with myeloproliferative neoplasms and it is thought that abnormal TGF signals cause many of the problems with blood cell formation in these diseases. The study design allows all patients to

myelodysplastic/myeloproliferative neoplasm

anemia

ruxolitinib

hydroxyurea

0 views
28 Jan, 2021
1 location

A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis

The purpose of this study is to evaluate the safety, tolerability, and efficacy of the combination of parsaclisib and ruxolitinib in subjects with myelofibrosis.

0 views
26 Jan, 2021
39 locations

Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.

Prospective study for the development of a non-invasive score for differentiating prefibrotic myelofibrosis from essential thrombocytosis and overt myelofibrosis.

0 views
23 Jan, 2021
2 locations

Decitabine With Ruxolitinib or Fedratinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

myeloproliferative neoplasms (tumors). Drugs used in chemotherapy, such as decitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by

essential thrombocythemia

wbc count

hydroxyurea

polycythemia

leukapheresis

7 views
24 Feb, 2021
1 location

Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm

This phase II trial studies how well ruxolitinib phosphate and azacytidine work in treating patients with myelofibrosis or myelodysplastic syndrome/myeloproliferative neoplasm. Ruxolitinib

mds/mpn-u

direct bilirubin

neutrophil count

essential thrombocythemia

polycythemia

65 views
26 Jan, 2021
1 location

Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia

This phase II trial studies the side effects of and how well sotatercept works in treating patients with myeloproliferative neoplasm-associated myelofibrosis or anemia. Sotatercept may stop the

direct bilirubin

anemia

conjugated bilirubin

vasectomy

blood transfusion

1052 views
24 Jan, 2021
2 locations

Venetoclax Added to Fludarabine + Busulfan Prior to Transplant for AML MDS and MDS/MPN

/myeloproliferative neoplasm-unclassifiable (MDS/MPN-unclassifiable) and are planning to have an allogeneic hematopoietic stem cell transplant ("bone marrow transplant"). The goal of this research study is to (1

myelodysplasia

chronic myelomonocytic leukemia

flow cytometry

remission

gilbert's syndrome

31 views
30 Jan, 2021
1 location

Filter By

Found 175 clinical trials